ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,000 | -42.9% | 15,250 | -29.1% | 0.01% | -50.0% |
| Q2 2020 | $63,000 | +1.6% | 21,500 | 0.0% | 0.01% | -17.6% |
| Q1 2020 | $62,000 | -3.1% | 21,500 | +34.4% | 0.02% | +21.4% |
| Q4 2019 | $64,000 | -1.5% | 16,000 | +10.3% | 0.01% | -6.7% |
| Q3 2019 | $65,000 | +16.1% | 14,500 | 0.0% | 0.02% | +15.4% |
| Q2 2019 | $56,000 | +1.8% | 14,500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $55,000 | – | 14,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |